STUB1 and obesity due to melanocortin 4 receptor deficiency: In summary, human genetic studies and murine models demonstrated that CHIP mutations were associated with obesity and that targeting CHIP-mutant cells with drugs such as metformin, nifedipine, MCC950, or anakinra may be a reasonable approach to treat CH.